Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quality of life and psychological well-being after withdrawal from hormone therapy in postmenopausal women
2005-004427-19Phase 4Active
- Sponsor
- Ludwig Maximilian University of Munich
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of conjugated estrogens and Medrogestone in menopause (2 arms), sponsored by Ludwig Maximilian University of Munich. Primary endpoint: Health-related quality of life at 6 months. Started Sep 2006; status: active.
02
Drugs
conjugated estrogensMedrogestone
03
Conditions
menopause
Beyond the preview
Go deeper on 2005-004427-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004427-19.